News and Comments

HALOZYME: FINANCING PEGPH20 IS WORTH RAISING MONEY

  Wednesday, February 05, 2014

Halozyme Therapeutics (HALO) stock has been a loser yesterday while other biotech firms have rebounded after dipping during the few days’ of an angry market. The reason for the stock decline was the announcement of pricing of Halozyme’s previously announced underwritten public offering of 7,692,307 shares of its common stock at a public offering price of $13.00 per share.  More...


Recent Postings


Archive


Tags

Biogen Idec (BIIB) Array Pharmaceuticals (ARRY) Genentech SERES THERAPEUTICS (MCRB) Incyte (INCY) AERIE PHARMACEUTICALS Sanofi (SNY) Cytokinetics (CYTK) Zerenex KITE (KITE) Exelixis (EXEL) Valeant Pharmaceuticals International (VRX) Dynavax (DVAX) Pluristem (PSTI) Auspex (ASPX) Ridaforolimus Sanofi-Aventis (SAN) Human Longevity (HLI) Herceptin ADVENTRIX (ANX) Biocryst (BCRX) ABBVIE (ABBV) Sangamo (SGMO) Agenus (AGEN) GlaxoSmithKline (GSK) NANTKWEST (NK) PTC Therapeutics (PTCT) Prosensa (RNA) Aimmune Therapeutics (AIMT) Ziofpharm (ZIOP) VANDA (VNDA) Dendreon (DNDN) Intermune (ITMN) Velcade (bortezomib) Revlimid (lenolidamide) Bristol-Myers Squibb (BMY) Alder Biopharmaceuticals (ALDR) KERYX (KERX) Alnylam (ALNY) Endometrial Cancer GUARDIAN HEALTH Mirati Therapeutics (MRTX) Intrexon (XON) Vitae Pharmaceuticals (VTAE) Seattle Genetics (SGEN) Rapamune Idenix (IDIX) SUNESIS PHARMACEUTICALS (SNSS) Onyx (ONXX) Sanofi (SNA) Elan (ELN) Trastuzumab-DM1 TOKAI (TKAOI) Inovio (INO) Regeneron (REGN) Galena (GALE) REGULUS (RGLS) Tysabri ZALTRAP™ Roche (RHHBY) BIOMARIN (BMRN) ARCA (ABIO) CompuGen (CGEN) Sarepta (SRPT) ISIS (ISIS) IDERA (IDRA) Abbott Laboratories (ABT) Sequenom (SQNM) Telaprevir Ariad (ARIA) Agenus (AGEN Amgen (AMGN) RenenxBio (RGNX) NEKTAR (NKTR)) Roche (ROCHE) ImmunoGen (IMGN) JUNO (JUNO) Anadys (ANDS) Anacor (ANAC) Prolor Biotech (PBTH) Micromet (MITI) HALOZYME (HALO) Editas (EDIT) Vertex (VRTX) OSI (OSIP) C4 Therapeutics Merck (MRK) Theravance Bio Pharma (TBPH) Human Genome Sciences (HGSI) Illumina (ILMN) Gilead (GILD) Xoma (XOMA) Benlysta (belimumab) Jazz Pharmaceuticals (JAZZ) Intercept (ICPT) Ionis (IONS) galapagos (GLPG) Multiple Myeloma ACADIA (ACAD) Theravance (THRX) SYNTA (SNTA)